Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2006-08-13 05:18:00 UTC |
---|
Update Date | 2022-09-22 18:34:17 UTC |
---|
HMDB ID | HMDB0003818 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | 5-Androstenediol |
---|
Description | 5-Androstenediol is a direct metabolite of the most abundant steroid produced by the human adrenal cortex, dehydroepiandrosterone (DHEA). 5-Androstenediol is less androgenic than 4-androstenediol, and stimulates the immune system. When administered to rats in vivo, 5-androstenediol has approximately 1/70 the androgenicity of DHEA, 1/185 the androgenicity of androstenedione, and 1/475 the androgenicity of testosterone (Wikipedia ). Because it induces production of white blood cells and platelets, 5-androstenediol is being developed as a radiation countermeasure as Neumune (HE2100). An intermediate in testosterone biosynthesis, found in the testis or the adrenal glands. 5-Androstenediol, derived from dehydroepiandrosterone by the reduction of the 17-keto group (17-hydroxysteroid dehydrogenases), is converted to testosterone by the oxidation of the 3-beta hydroxyl group to a 3-keto group (3-fydroxysteroid dehydrogenase). |
---|
Structure | [H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@H](O)CC[C@]12C InChI=1S/C19H30O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h3,13-17,20-21H,4-11H2,1-2H3/t13-,14-,15-,16-,17-,18-,19-/m0/s1 |
---|
Synonyms | Value | Source |
---|
(3beta,17beta)-Androst-5-ene-3,17-diol | ChEBI | 3beta,17beta-Dihydroxy-5-androstene | ChEBI | 3beta,17beta-Dihydroxyandrost-5-ene | ChEBI | 5-Androstenediol | ChEBI | Androst-5-en-3beta,17beta-diol | ChEBI | Androst-5-enediol | ChEBI | Hermaphrodiol | ChEBI | Androst-5-ene-3beta,17beta-diol | Kegg | Tetrabol | Kegg | (3b,17b)-Androst-5-ene-3,17-diol | Generator | (3Β,17β)-androst-5-ene-3,17-diol | Generator | 3b,17b-Dihydroxy-5-androstene | Generator | 3Β,17β-dihydroxy-5-androstene | Generator | 3b,17b-Dihydroxyandrost-5-ene | Generator | 3Β,17β-dihydroxyandrost-5-ene | Generator | Androst-5-en-3b,17b-diol | Generator | Androst-5-en-3β,17β-diol | Generator | Androst-5-ene-3b,17b-diol | Generator | Androst-5-ene-3β,17β-diol | Generator | Androstenediol | ChEBI | Androst-5-ene-3,17-diol | HMDB | b,17b-Diol | HMDB | delta-5-Androstenediol | HMDB | Delta5-Androstenediol | HMDB | 5 Androstene 3,17 diol | MeSH, HMDB | Delta 5-Androstenediol | MeSH, HMDB | Parke davis brand OF androstenediol | MeSH, HMDB | delta 5-Androstene-3 beta,17 beta-diol | MeSH, HMDB | 5 Androstene 3beta 17beta diol | MeSH, HMDB | Androst 5 ene 3 beta,17 beta diol | MeSH, HMDB | Androst-5-ene-3 beta,17 beta-diol | MeSH, HMDB | 5-Androstene-3beta-17beta-diol | MeSH, HMDB | Bisexovister | MeSH, HMDB | Delta 5 Androstenediol | MeSH, HMDB | 5-Androstene-3,17-diol | MeSH, HMDB | Androst 5 ene 3,17 diol | MeSH, HMDB | delta 5 Androstene 3 beta,17 beta diol | MeSH, HMDB |
|
---|
Chemical Formula | C19H30O2 |
---|
Average Molecular Weight | 290.4403 |
---|
Monoisotopic Molecular Weight | 290.224580204 |
---|
IUPAC Name | (1S,2R,5S,10R,11S,14S,15S)-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-7-ene-5,14-diol |
---|
Traditional Name | 5-androstenediol |
---|
CAS Registry Number | 521-17-5 |
---|
SMILES | [H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@H](O)CC[C@]12C |
---|
InChI Identifier | InChI=1S/C19H30O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h3,13-17,20-21H,4-11H2,1-2H3/t13-,14-,15-,16-,17-,18-,19-/m0/s1 |
---|
InChI Key | QADHLRWLCPCEKT-LOVVWNRFSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as androgens and derivatives. These are 3-hydroxylated C19 steroid hormones. They are known to favor the development of masculine characteristics. They also show profound effects on scalp and body hair in humans. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Steroids and steroid derivatives |
---|
Sub Class | Androstane steroids |
---|
Direct Parent | Androgens and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Androgen-skeleton
- 17-hydroxysteroid
- 3-beta-hydroxysteroid
- 3-beta-hydroxy-delta-5-steroid
- Hydroxysteroid
- 3-hydroxysteroid
- 3-hydroxy-delta-5-steroid
- Delta-5-steroid
- Cyclic alcohol
- Secondary alcohol
- Organic oxygen compound
- Hydrocarbon derivative
- Organooxygen compound
- Alcohol
- Aliphatic homopolycyclic compound
|
---|
Molecular Framework | Aliphatic homopolycyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Not Available | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
5-Androstenediol,1TMS,isomer #1 | C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CC[C@@H]2O[Si](C)(C)C | 2607.7 | Semi standard non polar | 33892256 | 5-Androstenediol,1TMS,isomer #2 | C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O[Si](C)(C)C)CC[C@@]43C)[C@@H]1CC[C@@H]2O | 2601.2 | Semi standard non polar | 33892256 | 5-Androstenediol,2TMS,isomer #1 | C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O[Si](C)(C)C)CC[C@@]43C)[C@@H]1CC[C@@H]2O[Si](C)(C)C | 2658.0 | Semi standard non polar | 33892256 | 5-Androstenediol,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)O[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C | 2891.1 | Semi standard non polar | 33892256 | 5-Androstenediol,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)O[C@H]1CC[C@@]2(C)C(=CC[C@H]3[C@@H]4CC[C@H](O)[C@@]4(C)CC[C@@H]32)C1 | 2871.3 | Semi standard non polar | 33892256 | 5-Androstenediol,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)O[C@H]1CC[C@@]2(C)C(=CC[C@H]3[C@@H]4CC[C@H](O[Si](C)(C)C(C)(C)C)[C@@]4(C)CC[C@@H]32)C1 | 3205.0 | Semi standard non polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental GC-MS | GC-MS Spectrum - 5-Androstenediol GC-MS (2 TMS) | splash10-004l-3920000000-6d05021a14366bfd40ba | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - 5-Androstenediol GC-MS (Non-derivatized) | splash10-004l-3920000000-6d05021a14366bfd40ba | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 5-Androstenediol GC-MS (Non-derivatized) - 70eV, Positive | splash10-03ea-0190000000-3ceb1bf6f3d53ee5d7e5 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 5-Androstenediol GC-MS (2 TMS) - 70eV, Positive | splash10-014i-2126900000-1bc7293586fc53c1c457 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 5-Androstenediol GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 5-Androstenediol GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5-Androstenediol 10V, Positive-QTOF | splash10-00dl-0090000000-551d3445a2c6cdfa61ee | 2016-08-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5-Androstenediol 20V, Positive-QTOF | splash10-05fr-0390000000-5cfc4d0f79fea1c885b8 | 2016-08-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5-Androstenediol 40V, Positive-QTOF | splash10-02bf-3890000000-e55a0a62bc36fe9049ec | 2016-08-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5-Androstenediol 10V, Negative-QTOF | splash10-000i-0090000000-d1deb080063b126f79ce | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5-Androstenediol 20V, Negative-QTOF | splash10-0079-0090000000-4d0bb4d4f197bc1e6846 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5-Androstenediol 40V, Negative-QTOF | splash10-0abc-1190000000-3f4cb9035ceae26a4876 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5-Androstenediol 10V, Positive-QTOF | splash10-0006-0090000000-9de0edc3a8b815dd7071 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5-Androstenediol 20V, Positive-QTOF | splash10-0abd-1940000000-90cd37c3652265920678 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5-Androstenediol 40V, Positive-QTOF | splash10-0aos-1900000000-76460d7bb552466d1504 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5-Androstenediol 10V, Negative-QTOF | splash10-000i-0090000000-c8c452fd99c6bb4f3631 | 2021-09-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5-Androstenediol 20V, Negative-QTOF | splash10-000i-0090000000-1ce9bb01eb35f26908c4 | 2021-09-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5-Androstenediol 40V, Negative-QTOF | splash10-000i-0090000000-aeda10893d01c46acf8c | 2021-09-25 | Wishart Lab | View Spectrum |
|
---|
General References | - Weusten JJ, Smals AG, Hofman JA, Kloppenborg PW, Benraad TJ: Early time sequence in pregnenolone metabolism to testosterone in homogenates of human and rat testis. Endocrinology. 1987 May;120(5):1909-13. [PubMed:3569120 ]
- Leszczynski DE, Schafer RM: Characterization of steroid hormone association with human plasma lipoproteins. Steroids. 1989 Jul;54(1):37-53. [PubMed:2815156 ]
- Szymczak J, Milewicz A, Thijssen JH, Blankenstein MA, Daroszewski J: Concentration of sex steroids in adipose tissue after menopause. Steroids. 1998 May-Jun;63(5-6):319-21. [PubMed:9618794 ]
- Tchernof A, Despres JP, Belanger A, Dupont A, Prud'homme D, Moorjani S, Lupien PJ, Labrie F: Reduced testosterone and adrenal C19 steroid levels in obese men. Metabolism. 1995 Apr;44(4):513-9. [PubMed:7723675 ]
- Vermeulen A, Deslypere JP: Intratesticular unconjugated steroids in elderly men. J Steroid Biochem. 1986 May;24(5):1079-83. [PubMed:2941625 ]
- Anderson DC, Child DF, Sutcliffe CH, Buckley CH, Davies D, Longson D: Cushing's syndrome, nodular adrenal hyperplasia and virilizing carcinoma. Clin Endocrinol (Oxf). 1978 Jul;9(1):1-14. [PubMed:209918 ]
- Dikkeschei LD, Wolthers BG, Willemse PH, van der Pol H, de Ruyter-Buitenhuis AW, Nagel GT: The determination of delta-5-androstenediol and its sulphate in serum and urine by gas chromatography-mass spectrometry. Clin Endocrinol (Oxf). 1993 Oct;39(4):469-74. [PubMed:8287574 ]
- Bonney RC, Reed MJ, Beranek PA, James VH: Metabolism of adrenal androgens by human endometrium and adrenal cortex. J Steroid Biochem. 1985 Sep;23(3):347-52. [PubMed:2995729 ]
- Mizokami A, Koh E, Fujita H, Maeda Y, Egawa M, Koshida K, Honma S, Keller ET, Namiki M: The adrenal androgen androstenediol is present in prostate cancer tissue after androgen deprivation therapy and activates mutated androgen receptor. Cancer Res. 2004 Jan 15;64(2):765-71. [PubMed:14744796 ]
- Higashi T, Takayama N, Shimada K: Enzymic conversion of 3beta-hydroxy-5-ene-steroids and their sulfates to 3-oxo-4-ene-steroids for increasing sensitivity in LC-APCI-MS. J Pharm Biomed Anal. 2005 Sep 15;39(3-4):718-23. [PubMed:15905063 ]
- Brown GA, Vukovich M, King DS: Testosterone prohormone supplements. Med Sci Sports Exerc. 2006 Aug;38(8):1451-61. [PubMed:16888459 ]
- Mendonca BB, Bloise W, Arnhold IJ, Batista MC, Toledo SP, Drummond MC, Nicolau W, Mattar E: Male pseudohermaphroditism due to nonsalt-losing 3 beta-hydroxysteroid dehydrogenase deficiency: gender role change and absence of gynecomastia at puberty. J Steroid Biochem. 1987 Dec;28(6):669-75. [PubMed:2826919 ]
- Brind JL: Direct radioimmunoassay of androstenediol-3-sulfate in the serum of normal men. Steroids. 1991 Jun;56(6):320-4. [PubMed:1926228 ]
- Jones DL, James VH: The identification, quantification and possible origin of non-polar conjugates in human plasma. J Steroid Biochem. 1985 Feb;22(2):243-7. [PubMed:3157025 ]
|
---|